In this study, to represent the molecular heterogeneity characterizing this tumor, we used U87MG, and the same ones engineered to over-express wild type (wt) EGFR or EGFRvIII and primary GBM patients-derived cells. This evidence concerns the gene EGFR and neoplasm.